Astegolimab

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

119 competitors in Chronic Obstructive Pulmonary Disease

#DrugCompanyPhaseTrials

1

Lunsekimig

Sanofi

Phase 3

32

CM310

KKeymed Biosciences Co.Ltd

Phase 3

13

Sildenafil ODT

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 2

24

Tozorakimab

AstraZeneca

Phase 3

25

Avinza

HHikma Pharmaceuticals LLC

Phase 2

16

Astegolimab

Roche

Phase 3

27

Calciferol

Jazz Pharmaceuticals

Preclinical

—8

Duragesic

CCephalon

Preclinical

29

Verekitug

UUpstream Bio Inc.

Phase 2

110

Narcan

SScienture

Preclinical

1Show 28 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Chronic Obstructive Pulmonary Disease2 trials

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease

Completed·Roche·Phase 2·NCT05037929·1,334 enrolled

A Phase III Open-Label Extension Study to Evaluate the Long-Term Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease

Active, not recruiting·Roche·Phase 3·NCT05878769·2,000 enrolled

Chronic Obstructive Pulmonary Disease (COPD)1 trial

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease

Completed·Roche·Phase 3·NCT05595642·1,380 enrolled

Unspecified1 trial

A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects

Completed·Roche·Phase 1·NCT06462118·78 enrolled

Details

Drug Info

Related News